Insider Buying Boosts Nuvectis Pharma as FDA Milestones Spark Investor Confidence
Inside Nuvectis Pharma’s buying spree, leadership’s confidence in upcoming regulatory milestones and targeted oncology therapies signals a potential rebound amid market volatility.
4 minutes to read